![Richard D. van Doren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard D. van Doren
Directeur Financier/CFO chez
JIYA ACQUISITION CORP.
Profil
Mr. Richard D.
van Doren, Jr., is a Chief Financial Officer at Versant Venture Management LLC, a Chief Financial Officer, Secretary & Director at Jiya Acquisition Corp., a Chief Financial Officer at Autobahn Labs, Inc., a Member-Regents Board at Junipero Serra High School, a Member-Deans Circle at University of San Francisco School of Management, a Chief Financial Officer at Kalaris Therapeutics, Inc. (Old) and a Chief Financial Officer at Nalo Therapeutics, Inc. He is on the Board of Directors at Jiya Acquisition Corp.
Mr. van Doren was previously employed as a Chief Financial Officer by Samsara BioCapital LLC, a Chief Operating & Financial Officer by Pacific Grove Capital LP, a Chief Financial Officer by Marcato Capital Management LP, a Chief Financial Officer by James Carlo Cannell, and a Principal by Pampanito Corp.
He received his undergraduate degree from the University of San Francisco.
Postes actifs de Richard D. van Doren
| Sociétés | Poste | Début |
|---|---|---|
| JIYA ACQUISITION CORP. | Directeur Financier/CFO | 01/08/2020 |
Junipero Serra High School
 Junipero Serra High School Other Consumer ServicesConsumer Services Operates high school | Corporate Officer/Principal | 01/09/2015 |
University of San Francisco School of Management
 University of San Francisco School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2009 |
Nalo Therapeutics, Inc.
 Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for cancer patients | Directeur Financier/CFO | - |
Autobahn Labs, Inc.
 Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Operates labs | Directeur Financier/CFO | 01/01/2019 |
Theia Therapeutics, Inc.
 Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Directeur Financier/CFO | - |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Directeur Financier/CFO | 01/04/2022 |
Anciens postes connus de Richard D. van Doren
| Sociétés | Poste | Fin |
|---|---|---|
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Directeur Financier/CFO | 01/04/2022 |
Pacific Grove Capital LP
 Pacific Grove Capital LP Investment ManagersFinance Provides investment management services | Directeur Financier/CFO | 01/01/2016 |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░ ░░ ░░░░░░░░░ ░ ░░░░░░░ | - |
Formation de Richard D. van Doren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Cannell Capital LLC
 Cannell Capital LLC Investment ManagersFinance Cannell Capital is an active investor that employs fundamental, bottom-up research in order to make investment decisions. The firm utilizes a long/short strategy that focuses on investments in publicly traded equities, generally small-cap companies, which primarily located in North America. Investment idea generation may be qualitative and/or quantitative in nature. Cannell Capital is an activist firm and is included in the SharkWatch50 as one of the 50 most prominent and impactful activist investors. | Finance |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Pampanito Corp.
 Pampanito Corp. Investment ManagersFinance Provides investment research | Finance |
Marcato Capital Management LP
 Marcato Capital Management LP Investment ManagersFinance Marcato Capital Management employs a value-oriented, concentrated long/short equity strategy with an activist and event-driven overlay. Their fund typically takes 10 to 15 positions in small- to mid-cap companies with less than $5 billion in market-cap. Marcato focuses on US and Canadian companies in the business services, retail, real estate and consumer sectors. They intend to hold positions for 2 years. Marcato Capital Management is an activist firm and is included in the SharkWatch50 as one the 50 most prominent activist investors. | Finance |
Pacific Grove Capital LP
Pacific Grove Capital LP Investment ManagersFinance Provides investment management services | Finance |
University of San Francisco School of Management
University of San Francisco School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Autobahn Labs, Inc.
Autobahn Labs, Inc. Medical/Nursing ServicesHealth Services Operates labs | Health Services |
Theia Therapeutics, Inc.
Theia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes treatments for prevalent retinal diseases | Health Technology |
Nalo Therapeutics, Inc.
Nalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for cancer patients | Health Technology |
Junipero Serra High School
Junipero Serra High School Other Consumer ServicesConsumer Services Operates high school | Consumer Services |
